Second generation antidepressant vs placebo medication
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with depressive disorders in children and adolescents
Second generation antidepressant may leads to higher suicide‐related outcome compared with placebo (by medication) (low certainty).
1 finding from 1 review
- Newer generation antidepressants for depressive disorders in children and adolescents 2012 · Cochrane Headline outcomes onlyRR 1.58 [1.02, 2.45]17 studies · 3229 participantsLow